Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer

Thoracic Surgery Clinics

Volumn 17, Issue 2, 2007, Pages 251-259

  Chang, Joe Y ^a   Roth, Jack A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CENTER; CANCER RADIOTHERAPY; CANCER STAGING; DOSE RESPONSE; HUMAN; IMAGING; IMMOBILIZATION; LUNG NON SMALL CELL CANCER; LYMPH NODE IRRADIATION; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; STEREOTAXIC SURGERY; SURGICAL TECHNIQUE; SURVIVAL RATE; SYSTEMIC DISEASE; TARGET ORGAN; TOXICITY; TREATMENT INDICATION; TUMOR LOCALIZATION; TUMOR VOLUME; WHOLE BODY RADIATION;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PNEUMONECTOMY; RADIATION DOSAGE; RADIOSURGERY; TREATMENT OUTCOME;

EID: 34249849046     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2007.03.011     Document Type: Review

References (31)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin 56 2 (2006) 106-130
2. Mountain C. The international system for staging lung cancer. Semin Surg Oncol 18 2 (2000) 106-115
3. Dosoretz D., Galmarini D., Rubenstein J., et al. Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 27 (1993) 507-516
4. Kaskowitz L., Graham M., Emami B., et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27 (1993) 517-523
5. Fang L., Komaki R., Allen P., et al. Comparison of outcomes for patients with medically inoperable stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 66 1 (2006) 108-116
6. Fletcher G. Clinical dose response curves of human malignant epithelial tumours. Br J Cancer 46 (1973) 1-12
7. Dosoretz D., Katin M., Blitzer P., et al. Medically inoperable lung carcinoma: the role of radiation therapy. Semin Radiat Oncol 6 (1996) 98-104
8. Sibley G., Jamieson T., Marks L., et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 40 1 (1998) 149-154
9. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 51 3 (2001) 666-670
10. Onishi H., Kuriyama K., Komiyama T., et al. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer 45 1 (2004) 45-55
11. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 5 (2005) 1427-1431
12. McGarry R., Papiez L., Williams M., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 63 4 (2005) 1010-1015
13. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 30 (2006) 4833-4839
14. Xia T., Li H., Sun Q., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66 (2006) 117-125
15. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma clinical outcome in 245 subjects in a Japanese multiinstitutional study. Cancer 101 7 (2004) 1623-1631
16. Liu H., Choi B., Zhang J., et al. Assessing respiration-induced tumor motion and margin of internal target volume for image-guided radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys 63 Suppl 1 (2005) S30-S3S
17. Ramsey C., Scaperoth D., Arwood D., et al. Clinical efficacy of respiratory gated conformal radiation therapy. Med Dosim 24 2 (1999) 115-119
18. Rosenzweig K., Hanley J., Mah D., et al. The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48 1 (2000) 81-87
19. Sixel K., Aznar M., and Ung Y. Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients. Int J Radiat Oncol Biol Phys 49 1 (2001) 199-204
20. Nehmeh S., Erdi Y., Pan T., et al. Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys 31 (2004) 3179-3186
21. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. Bethesda (MD); 1993. Report No.: 50.
22. Chang J., Balter P., Liao Z., et al. Preliminary report of image-guided hypofractionated stereotactic body radiotherapy to treat patients with medically inoperable stage I or isolated peripheral lung recurrent non-small cell lung cancer. Int J Radiat Oncol Biol Phys 66 3 (2006) S480
23. Bradley J., Thorstad W., Mutic S., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59 1 (2004) 78-86
24. Krol A., Aussems P., Noordijk E., et al. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 34 2 (1996) 297-302
25. Sulman E., Chang J., Liao Z., et al. Exclusion of elective nodal irradiation does not decrease local regional control of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 63 Suppl 1 (2005) S226-S227
26. Winton T., Livingston R., Johnson D., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352 25 (2005) 2589-2597
27. Strauss G., Herndon J., Maddaus M., et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): report of cancer and leukemia group B (CALGB) protocol 9633. J Clin Oncol 22 14 (2004) 7019
28. Arriagada R., Bergman B., Dunant A., et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350 4 (2004) 351-360
29. Ginsberg R., Rubinstein L., and Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 60 (1995) 615-622
30. Naruke T., Tsuchiya R., Kondo H., et al. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 71 6 (2001) 1759-1764
31. Allen M.S., Darling G.E., Pechet T.T., et al. Resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 81 (2006) 1013-1020